A Unique Comprehensive Approach to Bone Turnover Management
Immunodiagnostic Systems Limited (referred to hereafter as IDS) offers a unique and full panel of bone turnover markers, for the measurement and monitoring of bone resorption and formation. Our complete bone offering provides the tools for research and routine clinical laboratories, to provide highly accurate and reliable results.
Throughout life, old bone is constantly removed (resorption) and replaced by new bone (formation). This continual process is essential for the maintenance of healthy bone mass and micro-architecture. Accelerated bone mass resorption can occur to women in postmenopausal years. Osteoporosis is a disease characterised by low bone density and reduced structural strength of the bone, leading to increased risk of bone fracture. Osteoporosis affects approximately 30% of postmenopausal women in the US and Europe.1 Around the world 1 in 3 women and 1 in 5 men are at risk of osteoporotic fracture.1
Changes in bone turnover can be assessed by using the comprehensive IDS bone turnover test panel, which offers laboratories an in-vitro alternative to ex-vivo and in-vivo methods. Use of IDS bone turnover assays, enables clinicians to quantify bone formation and resorption levels in order to assist with monitoring.
Portfolio | Certification | Clinical Area | Product Type | RUO/IVD |
---|---|---|---|---|
CTX-I (CrossLaps®) | CE Marked |
Automated | IVD | |
Intact PINP | CE Marked |
Automated | IVD | |
N-MID® Osteocalcin | CE Marked |
Automated | IVD | |
Ostase® BAP | CE Marked |
Automated | IVD | |
TRAcP 5b (BoneTRAP®) | CE Marked |
Automated | IVD | |
Alpha CrossLaps® (CTX-I) EIA | CE Marked |
Manual | IVD | |
BoneTRAP® (TRAcP 5b) ELISA | CE Marked |
Manual | IVD | |
Ostase® BAP EIA | CE Marked |
Manual | IVD | |
N-MID® Osteocalcin ELISA | CE Marked |
Manual | IVD | |
Serum Crosslaps® (CTX-I) ELISA | CE Marked |
Manual | IVD | |
Urine BETA CrossLaps® (CTX-I) ELISA | FDA Cleared |
Manual | IVD | |
Urine CrossLaps® (CTX-I) EIA | CE Marked |
Manual | IVD |